Clinical Trials
Closed
Phase
Accrual
65%
Published
SWOG Clinical Trial Number
SWOG-9104
Evaluation of Doxorubicin/Vinblastine Combined with Inhibitors (Trifluoperazine/Verapamil) of P-Glycoprotein in Patients with Advanced Renal Cell Carcinoma, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
09-01-1992
Closed
09-01-1994
Closed
Phase
Accrual
86%
Published
SWOG Clinical Trial Number
SWOG-9005
Double Blind Randomized Trial of the Anti-Progestational Agent Mifepristone In The Treatment of Unresectable Meningioma, Phase III
Research Committee(s)
Brain Cancer
Activated
08-15-1992
Closed
07-01-1998
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9143
Closed
Phase
Accrual
57%
Published
SWOG Clinical Trial Number
SWOG-9150
Evaluation of Topotecan in Gastric Cancer, Phase II
Research Committee(s)
Gastrointestinal Cancer
Activated
07-15-1992
Closed
10-15-1993
Closed
Phase
Accrual
58%
Published
SWOG Clinical Trial Number
SWOG-8955
Treatment of Stage D, Hormone Refractory Carcinoma of the Prostate with 5/Fluorouracil and Roferon-A®, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
06-15-1992
Closed
11-01-1993
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9116
Evaluation of Piroxantrone in Disseminated Malignant Melanoma, Phase II
Activated
06-01-1992
Closed
10-01-1993
Closed
Phase
Accrual
62%
Published
SWOG Clinical Trial Number
SWOG-9124
Evaluation of Edatrexate (EDX) in Patients with Relapsed or Refractory Germ Cell Tumors, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
06-01-1992
Closed
09-01-1996
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9032
A Controlled Trial of Cyclosporine As A Chemotherapy-Resistance Modifier in Blast Phase-Chronic Myelogenous Leukemia
Research Committee(s)
Leukemia
Activated
06-01-1992
Closed
03-01-1998
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-9135
A Phase II Trial of Taxol and Granulocyte-Colony Stimulating Factor (G-CSF) in Patients with Pancreatic Adenocarcinoma
Research Committee(s)
Gastrointestinal Cancer
Activated
06-01-1992
Closed
01-15-1993
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9134
A Phase II Trial of Taxol and Granulocyte-Colony Stimulating Factor (G-CSF) in Patients with Advanced Soft-Tissue Sarcoma
Activated
06-01-1992
Closed
06-15-1993
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9122
Evaluation of 5-Fluorouracil By Intermittent Infusion in Combination with Alpha-Interferon for Patients with Advanced Renal Cell Carcinoma, Phase II
Research Committee(s)
Genitourinary Cancer
Activated
06-01-1992
Closed
10-15-1993
Closed
Phase
Accrual
53%
Published
SWOG Clinical Trial Number
SWOG-9138
Evaluation of Fazarabine for Advanced (Stage IV) Non-Small Cell Carcinoma of the Lung, Phase II
Activated
05-15-1992
Closed
07-15-1993
Closed
Phase
Accrual
46%
Published
SWOG Clinical Trial Number
SWOG-9058
A Phase II Trial of Intravenous Vinorelbine (Navelbine®) in Previously Untreated Extensive Small Cell Lung Carcinoma
Research Committee(s)
Lung Cancer
Activated
05-15-1992
Closed
06-01-1995
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9019
A Pilot Study of Chemotherapy Plus Radiation Therapy for Selected IIIb (No Malignant Effusion) Non-Small Cell Lung Cancer
Research Committee(s)
Lung Cancer
Activated
04-15-1992
Closed
12-01-1995
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9051
Pilot Evaluation of Combined Hepatic Chemoembolization and Systemic Chemotherapy with 5-FU and Folinic Acid for Metastatic Adenocarcinoma of the Colon and Rectum, Phase II
Research Committee(s)
Gastrointestinal Cancer
Activated
04-15-1992
Closed
04-01-1995
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9035
Randomized Trial of Adjuvant Immunotherapy with an Allogeneic Melanoma Vaccine for Patients with Intermediate Thickness, Node Negative Malignant Melanoma (T3N0M0), Phase III.
Research Committee(s)
Melanoma
Activated
04-15-1992
Closed
11-15-1996
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9151
Evaluation of Topotecan in Hepatoma, Phase II
Research Committee(s)
Gastrointestinal Cancer
Activated
02-01-1992
Closed
06-15-1993
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-9139
Adjuvant Therapy of Primary Osteogenic Sarcomas, Phase II
Activated
12-15-1991
Closed
12-01-1996
Closed
Phase
Accrual
66%
Published
SWOG Clinical Trial Number
SWOG-9119
Primary Chemotherapy of Poor Prognosis Soft Tissue Sarcomas, Phase II
Activated
12-15-1991
Closed
06-15-1998
Closed
Phase
Accrual
64%
Published
SWOG Clinical Trial Number
SWOG-9136
Biologic Parameters in Soft Tissue Sarcomas: A Companion Study to Select Southwest Oncology Group Clinical Trials with Soft Tissue Sarcoma Patients
Research Committee(s)
Sarcoma
Activated
12-15-1991
Closed
06-15-1998